PLoS Med. 2026 Apr 15;23(4):e1005056. doi: 10.1371/journal.pmed.1005056. eCollection 2026 Apr.
ABSTRACT
Circulating microbiome-related metabolites have emerged as promising biomarkers for coronary heart disease. A recent multi-stage study in PLOS Medicine strengthens signal prioritization but highlights the persistent gap between association and causality.
PMID:41984779 | DOI:10.1371/journal.pmed.1005056